Low grade malignant schwannoma of tibial nerve

Introduction: The aim of this paper is to report a rare case of a sizeable low grade malignant schwannoma of the posterior tibial nerve and to underline the method of treatement. Case Report: A 37-year-old white male presented himself with a slowly growing mass in his left calf. According to the slower rate of growing and to the mobility of the tumor diagnosis was oriented to a benign lesion of posterior calf muscles. The decision was to perform a excisional biopsy of the tumor. The examined tumor was classified as low-grade malignant peripheral nerve sheath tumor. We did not have a suspicion of malignancy in our case due to the slowly growing rate. The treatment performed was surgical excision of the tumor with adequate exposure of normal nerve proximally and distally. Conclusion: Clinical and radiological findings of this case suggested a benign tumor. According to this, the decision was to perform a excisional biopsy of the tumoral mass and not only a biopsy first. (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 5 No. 10, October 2014. ISSN – [0976-3198] Int J Case Rep Images 2014;5(10):671–674. www.ijcasereportsandimages.com Orban et al. 671 CASE REPORT OPEN ACCESS Low grade malignant schwannoma of tibial nerve Horia Orban, Gabriel Stan, Boris Feghiu, Mihaela Dragusanu, George Simion


INtroductIoN
The most common forms of schwannomas are benign. They originate from the sheath of Schwann surrounding peripheral nerve fibers and malignant transformation is uncommon. The patients may have a history of neurofibromatosis type I (NF-1) or tumors may arise spontaneously [1]. Benign peripheral nerve sheath tumor appears as an asymptomatic, slowly growing lesion, while malign lesion is aggressive. Literature studies showed that malignant peripheral nerve sheath tumors are aggressive, presenting as a rapidly growing and painful lump. These tumors are associated with poor prognosis unless wide excision of the tumor is undertaken before local invasion or distant metastasis can occur [2]. Some authors advocated that the operation undertaken, if possible, should be the amputation. Alternatively, where amputation is not possible the alternative must be the largest and most radical excision possible [3]. According to Musculoskeletal Tumor Society, majority of the patients had Stage II (high grade but not metastasized) or Stage III (plus metastasis) tumors. The aim of this paper is to report a rare case of a sizeable low grade malignant schwannoma of the posterior tibial nerve and to underline the methods of treatment. www.ijcasereportsandimages.com Orban et al. 672

cAsE rEPort
A 37-year-old white male presented himself with a slowly growing mass in his left calf. He was complaining of mild pain and paresthesia of 12 months duration. Loss of sensation in the sole of the foot was observed. On physical examination, a firm painful mass was palpable in the posterior compartment of the left calf. The tumor was relatively mobile in relation to adjacent structures. Also the pain was exacerbate by the motion and prolonged orthostatism. Laboratory testing showed no alteration of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), fibrinogen or alkaline phosphatase (ALP). The X-ray of lungs was normal. In magnetic resonance imaging (MRI) scan the lesion appeared to be ovalar and multinodular. It measured 90x71x46 mm occurring the distal third of calf posterior compartment. There was a high intensity signal in T2-weighted images and low intensity signal in T1-weighted images ( Figure 1). No invasion of the surrounding bones was observed.
According to the slower rate of growing and to the mobility of the tumor diagnosis was oriented to a benign lesion of posterior calf muscles. The decision was to perform a excisional biopsy of the tumor. Intraoperatively, we discovered that the tumor had a posterior tibial nerve sheath origin ( Figure 2). We performed a marginal excision of this tumor and sent it for anatomopathological examination (Figures 3 and 4).
The examined tumor consists of bundles of irregular spindle cells with moderate cellular density and atypias, mottled appearance, with hyperchromatic nuclei which vary in shape (ellipsoidal, strip-like or comma shape) and the absence of perivascular cluster of cells; predominant architecture closely resembling neurofibroma (1 point). The mitotic rate was low, with 2-4 mitoses/high power field (1 point) and the necrosis was absent (1 point). According to obtained score of 3 points, we classified the tumor as low-grade malignant peripheral nerve sheath tumor (MPNST) ( Figure 5).

dIscussIoN
As we mentioned before, most MPNSTs are high grade. These tumors have a highly aggressive clinical evolution. Ducatman reported in his study of 120 cases that 18% of MPNSTs were low grade. Although no significant correlation has been noted between survival and histological grade, 60% of patients with MPNST die. Survival rates at five and 10 years are 34% and 23%, respectively [4]. The diagnosis of low grade MPNST is not easy due to similarity with neurofibromatosis. Also the pathological features of low grade MPNST often overlap with those of other soft tissue tumors [5]. The diagnosis is particularly difficult when MPNST has multiple mesenchymal differentiations, and should be differentiated from rhabdomyosarcoma, osteosarcoma, chondrosarcoma or liposarcoma [6]. The MPNST   with glandular differentiation must be differentiated from metastatic carcinoma. In metastatic carcinoma, spindle-shaped cells around the glandular structures are often reactive proliferating fibroblasts. Full physical examination should be performed for differential diagnosis [7]. The MPNSTs are histologically characterized by hypercellularity, cytological atypia and increased mitotic activity as our study found [8]. Kar et al. in their study showed that grade of the tumor was a significant prognostic factor for survival. Cellular differentiation emerged as a significant prognostic factor for disease free survival in both univariate and multivariate analysis.
Mitosis and tumor necrosis had no impact on survival. The index of increasing proliferation was correlated with grade of the tumor and with prognosis of the disease [9]. Other studies also showed that grade of the tumor, necrosis vascular invasion, and presence of mitosis have significant influence on survival [8]. Scheithauer et al. have reported the divergent differentiation as a significant adverse prognostic marker for MPNST [10]. Regarding treatment attitude, Kar et al. performed, among the 15 patients with extremity MPNST, limb salvage surgery in 10 patients, and amputations or disarticulation in five patients, either for primary or recurrent tumor with neurovascular encasement and extensive soft tissue with bone involvement. The five-year overall and disease free survival was 58%. Fifty-four percent of the patients developed relapse of disease, including local, systemic, and second primary sarcomas of same histology (multifocal MPNST). Authors suggested that radical surgical resection is the treatment of choice in MPNST, and that amputations are indicated only when wide excision is not feasible and in patients with severely compromised limb function. The cut end of the nerve should be sent for frozen section to assess the tumor free margin of the resection [9]. Non-conservative surgery is associated with better local control but not with better survival in these patients, as studies previously reported [11]. Matejcik showed that good results were obtained in those patients who did not undergo any attempt for biopsy first, but who received radical excision from the beginning [12]. The only argument for performing a biopsy is suspicion of malignancy [13]. We did not have a suspicion of malignancy in our case due to the slowly growing rate, non-invasive tendency and to the mobility of the tumor. The treatment performed was surgical excision of the tumor with adequate exposure of normal nerve proximally and distally.

coNcLusIoN
This case is a rare low grade malignant schwannoma of the posterior tibial nerve. Clinical and radiological findings of this case suggested a benign tumor. According to this, the decision was to perform a excisional biopsy of the tumoral mass and not only a biopsy first. Despite the malignancy, cellular differentiation and tumoral low grade could be favorable prognostic factors for disease free and overall survival after marginal excision of the tumor. Further follow-up of this case is needed. *********

Author contributions
Horia Orban -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

AN INTRODUCTION
Edorium Journals: On Web

About Edorium Journals
Edorium Journals is a publisher of high-quality, open access, international scholarly journals covering subjects in basic sciences and clinical specialties and subspecialties.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Mentored Review Articles (MRA)
Our academic program "Mentored Review Article" (MRA) gives you a unique opportunity to publish papers under mentorship of international faculty. These articles are published free of charges.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle. Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.